Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma

Abstract excerpt

Over a decade of sequencing-based genomics research has unveiled a diverse somatic mutation landscape across patients with pancreatic ductal adenocarcinoma (PDAC), and the identification of druggable mutations has aligned with the development of novel targeted therapeutics. However, despite these advances, direct translation of years of PDAC genomics research into the clinical care of patients remains a critical...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Pancreatic and Hepatic Oncology Research
• Share to Renal cell carcinoma treatment